Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Evaluating cognitive rehabilitation in multiple sclerosis: on the bumpy road to establishing evidence.
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].
TH17 cell differentiation is regulated by the circadian clock.
Does the patient know best? Quality of life assessment in multiple sclerosis trials.
Altered inter-subregion connectivity of the default mode network in relapsing remitting multiple sclerosis: a functional and structural connectivity study.
Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica.
The Impact of a Patient Support Program for Multiple Sclerosis on Patient Satisfaction and Subjective Health Status.
Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRI.
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.
Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study.
Ethical challenges in paediatric clinical trials in multiple sclerosis.
Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume.
Immune modulation by a tolerogenic MOG10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model.
Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period.
Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis.
Interferon Beta and Glatiramer Acetate Therapy.
A web-based electronic neurology referral system: a solution for an overburdened healthcare system?
Expert recommendations to personalization of medical approaches in treatment of Multiple Sclerosis: an overview of family planning and pregnancy.
[Differential diagnosis between multiple sclerosis and neurological presentations of HIV-infection: a literature review and a case report].
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
Memory impairment in multiple sclerosis is due to a core deficit in initial learning.
Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis.
Regional but Not Global Brain Damage Contributes to Fatigue in Multiple Sclerosis.
Pages
« first
‹ previous
…
205
206
207
208
209
210
211
212
213
…
next ›
last »